PUBLISHER: The Business Research Company | PRODUCT CODE: 1653265
PUBLISHER: The Business Research Company | PRODUCT CODE: 1653265
Pre Filled Syringes Global Market Report 2025
Pre-filled syringes refer to syringes that come pre-loaded with the substance intended for injection, facilitating the accurate delivery of the contents to the desired location.
The primary types of pre-filled syringes include conventional pre-filled syringes and safety pre-filled syringes. Conventional pre-filled syringes typically contain a single-dose packet of vaccines, with a manufacturer-fixed needle designed for one-time use. After application, the syringe is disposed of. Safety pre-filled syringes, on the other hand, contain a single-dose packet of vaccine intended for self-administration by patients who require regular injections in a home setting. Needles for these syringes are crafted from materials such as glass and plastic, and the syringes come in various forms, including single-chamber pre-filled syringes, dual-chamber pre-filled syringes, and customized pre-filled syringes. These pre-filled syringes find applications in a range of medical conditions such as diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others.
The pre-filled syringes market research report is one of a series of new reports from The Business Research Company that provides pre-filled syringes market statistics, including pre-filled syringes industry global market size, regional shares, competitors with a pre-filled syringes market share, detailed pre-filled syringes market segments, market trends and opportunities and any further data you may need to thrive in the pre-filled syringes industry. The pre-filled syringe market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pre filled syringes market size has grown rapidly in recent years. It will grow from $8.3 billion in 2024 to $9.46 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to growth in the pharmaceutical and biotechnology industry, expansion of biologics and vaccines, demand for user-friendly and precise drug delivery, increase in home healthcare and self-administration, regulatory standards for drug safety and packaging.
The pre filled syringes market size is expected to see rapid growth in the next few years. It will grow to $16.42 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to customized pre-filled syringe solutions for specific drugs, expansion of biodegradable and sustainable materials, innovation in connected and smart syringes, increased use in telemedicine and telehealth, adoption in long-acting injectable medications. Major trends in the forecast period include regulatory compliance in pre-filled syringe safety, smart and connected syringes for precise dosing, biodegradable and eco-friendly syringe materials, personalized syringe solutions for patient populations, transparency and traceability in drug delivery.
The pre-filled syringe market is anticipated to experience significant growth due to the increasing prominence of home-based healthcare during the forecast period. Home-based healthcare involves providing medical treatment and support to patients in their residences, aiming to facilitate recovery, manage illnesses, and deliver care in the convenience of patients' homes. The pre-filled syringe market is poised for substantial expansion, aligning with the changing healthcare landscape by ensuring precise dosing, minimizing contamination risks, and enhancing patient compliance. This contributes to an elevated quality of care delivered within the comfort of patients' homes. For example, data from the National Association for Home Care and Hospice in February 2023 reveals that around 12 million Americans annually receive home healthcare, with this number expected to continue growing. Hence, the surge in home-based healthcare is anticipated to drive market growth in the forecast period.
The increasing demand for oncology treatment is anticipated to drive growth in the pre-filled syringe market. Oncology treatment encompasses the medical care and therapies employed to diagnose, manage, and treat cancer, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapies. This heightened demand is fueled by the growing prevalence of cancer, advancements in treatment options, enhanced early detection methods, and a rising aging population, all of which lead to a greater need for effective cancer care. Pre-filled syringes play a crucial role in oncology treatment by providing precise, ready-to-use doses of chemotherapy agents and biologic therapies, simplifying administration, and enhancing patient compliance. For example, according to Macmillan Cancer Support, a UK-based charity dedicated to providing practical, emotional, and financial assistance to those affected by cancer to improve their quality of life, the number of individuals living with cancer in the UK is projected to surpass 3 million currently, reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising demand for oncology treatment will propel the growth of the pre-filled syringe market.
Companies operating in the pre-filled syringes market are increasingly investing in next-generation prefilled syringes, incorporating features that enable healthcare professionals to track and access data. Next-generation pre-filled syringes refer to technologically advanced syringes designed to enhance drug delivery, elevate patient safety, and provide additional features like connectivity and usability. In September 2022, Becton, Dickinson and Company (BD), a US-based medical technology company, introduced a next-generation glass prefillable syringe designed to meet rigorous standards for processability, cosmetics, integrity, and contamination. This innovative syringe, known as BD Effivax Glass Prefillable Syringe, was developed in collaboration with leading pharmaceutical companies to address the evolving requirements of vaccine production.
Leading healthcare companies in the pre-filled syringe market are seeking approval for innovative products, such as single-dose pre-filled syringes, to broaden their presence in the healthcare sector. Single-dose pre-filled syringes, which contain a disposable syringe preloaded with medication liquid for injection, offer a convenient solution for administering treatments. For example, in March 2023, the Food and Drug Administration (FDA) granted approval for Emerphed (ephedrine sulfate injection) in 25 mg/5 mL and 50 mg/10 mL single-dose pre-filled syringes manufactured by Nexus Pharmaceuticals Inc., a US-based pharmaceutical company. This marks the FDA's approval of the first 10-milliliter (mL) pre-filled syringe for ephedrine sulfate injection.
In January 2022, Nordic Pharma B.V., a pharmaceutical company based in the Netherlands, acquired the rights to the ALTIM pre-filled syringe from Sanofi. This acquisition aims to strengthen Nordic Pharma's portfolio in the rheumatology sector. The company intends to optimize the manufacturing process of the product to reintroduce it to the market, addressing the ongoing demand from clinicians for this treatment option. Sanofi S.A. is a pharmaceutical and healthcare company headquartered in France.
Major companies operating in the pre filled syringes market include Becton, Dickinson and Company, Gerresheimer AG, Schott & Associates Glass Technology Laboratory, West Pharmaceutical Services Inc., Baxter International, Nipro Corporation, Terumo Corporation, Vetter Pharma International GmbH, Stevanato Group SPA, Shandong Weigao Group Medical Polymer Company Ltd., Novartis AG, Catalent Inc., Unilife Corporation, Eli Lilly and Company, Bayer AG, Pfizer Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., AbbVie Inc., Owen Mumford Holdings Ltd., AptarGroup Inc., Medtronic Plc, Abbott Laboratories, Fresenius Kabi India Pvt. Ltd., Medical Protective Ltd., Mylan NV, Elcam Medical Inc., YPSOMED Holding AG, Oval Medical Technologies, SHL Medical, ACASI Machinery Inc., Bespak Holdings Ltd., BioPharma Solutions, Catalent Pharma Solutions, Credence MedSystems Inc., Hasemeier Inc., Intas Pharmaceuticals Ltd., Intelicure Lifesciences, Mycoscience Labs
Europe was the largest region in the prefilled syringes market in 2024. The regions covered in the prefilled syringes market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the pre-filled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
The pre-filled syringes market consists of sales of glass prefilled syringes and plastic prefilled syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Reasons to Purchase
Scope
Table of Contents
1. Executive Summary
2. Pre Filled Syringes Market Characteristics
3. Pre Filled Syringes Market Trends And Strategies
4. Pre Filled Syringes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Pre Filled Syringes Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pre Filled Syringes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pre Filled Syringes Market Growth Rate Analysis
- 5.4. Global Pre Filled Syringes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pre Filled Syringes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pre Filled Syringes Total Addressable Market (TAM)
6. Pre Filled Syringes Market Segmentation
7. Pre Filled Syringes Market Regional And Country Analysis
8. Asia-Pacific Pre Filled Syringes Market
9. China Pre Filled Syringes Market
10. India Pre Filled Syringes Market
11. Japan Pre Filled Syringes Market
12. Australia Pre Filled Syringes Market
13. Indonesia Pre Filled Syringes Market
14. South Korea Pre Filled Syringes Market
15. Western Europe Pre Filled Syringes Market
16. UK Pre Filled Syringes Market
17. Germany Pre Filled Syringes Market
18. France Pre Filled Syringes Market
19. Italy Pre Filled Syringes Market
20. Spain Pre Filled Syringes Market
21. Eastern Europe Pre Filled Syringes Market
22. Russia Pre Filled Syringes Market
23. North America Pre Filled Syringes Market
24. USA Pre Filled Syringes Market
25. Canada Pre Filled Syringes Market
26. South America Pre Filled Syringes Market
27. Brazil Pre Filled Syringes Market
28. Middle East Pre Filled Syringes Market
29. Africa Pre Filled Syringes Market
30. Pre Filled Syringes Market Competitive Landscape And Company Profiles
31. Pre Filled Syringes Market Other Major And Innovative Companies
32. Global Pre Filled Syringes Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pre Filled Syringes Market
34. Recent Developments In The Pre Filled Syringes Market
35. Pre Filled Syringes Market High Potential Countries, Segments and Strategies
36. Appendix
